Register
Login:
Share:
Email Facebook Twitter




Avacta Share Chat (AVCT)

AVCT Share Chat - RSS Feed

Share Price: 119.50Bid: 119.00Ask: 120.00Change: 0.00 (0.00%)No Movement on Avacta
Spread: 1.00Spread as %: 0.84%Open: 119.50High: 119.50Low: 119.50Yesterday’s Close: 119.50


Share Discussion for Avacta


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

Wisheyedbortum
Posts: 544
Observation
Opinion:Strong Buy
Price:1.30
Affimers
17 Jul '15
The latest release from Chris Miller contains some interesting testimonials about Affimers and although most of it goes straight over my head there does seem to be an indication that this technology is gathering momentum pretty quickly.
 
Wisheyedbortum
Posts: 544
Answer
Opinion:No Opinion
Price:1.31
Suki
15 Jul '15
Absolutely, but I am hoping that the £22mil may shorten your 2-5 year estimate as I am knocking on a bit. Ha Ha.
sukithedog
Posts: 547
Premium Chat Member
Off Topic
Opinion:Strong Buy
Price:1.31
Wisheyedbortum
15 Jul '15
I think the important point is £22m has been raised at a slight discount which shows me that there is very good appetite for AVACTA

Rene Is a good example I agree

I really believe in at least 2 -5 years we have a massive multi bagger on our hands
Wisheyedbortum
Posts: 544
Answer
Opinion:Strong Buy
Price:1.31
hopesprings
15 Jul '15
I agree with that, RENE being a typical example.
Wisheyedbortum
Posts: 544
Observation
Opinion:Strong Buy
Price:1.29
suki
15 Jul '15
Yes, the placement has been allocated which is great news and long term the £22mil will accelerate the progress considerably, but that kind of dilution has never been particularly welcome. However, I shouldn't complain really as I am still shifting money about in ISAs etc so as to make the most of Avacta's inevitable rise. I am also into RENE in a big way, another very promising company.
hopesprings
Posts: 97
Off Topic
Opinion:Strong Buy
Price:1.29
HENDERSON & WOODFORD
15 Jul '15
I EXPECT THAT HENDERSON WILL SUBSCRIBE AS THEY ALREADY OWN 16.5% OF THE COMPANY.
I WOULD NOT BE SURPRISED TO FIND WOODFORD BUYING.
IT SUITS THEIR STATED OBJECTIVES OF INVESTING IN MEDICAL COMPANIES WITH GREAT PRODUCTS
WHICH NEED EXTRA CASH TO MOVE THEM ON EXPONENTIALY.
sukithedog
Posts: 547
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:1.28
RE: Oh dear....
15 Jul '15
Great news, raised more money @ 2 percent discount , good show of faith
Price should rise on this
Wisheyedbortum
Posts: 544
Off Topic
Opinion:No Opinion
Price:1.28
Oh dear....
15 Jul '15
...another 1.76 billion shares. Still, £22million should move things along a bit.
sukithedog
Posts: 547
Premium Chat Member
Off Topic
Opinion:Strong Buy
Price:1.27
still way to low
7 Jul '15
07-Jul-15 numis Buy - 1.62 Reiteration
hopesprings
Posts: 97
Off Topic
Opinion:Strong Buy
Price:1.24
MODERNA NUMBER 1 CHOICE OF CNBC
7 Jul '15
The Moderna arrangement has immense scope.

Moderna Therapeutics were chosen by CNBC as number 1 in a list of companies that are revolutionising the business landscape of America.See...CNBC disruptors.For Moderna to have identified the potential of Avacta affirmers is very impressive.
Be happy




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.